期刊文献+

卒中高危人群筛选与干预策略——上海市南汇区70万人群卒中预防试点讨论分析 被引量:5

A Strategy for Screening High Risk Population and Intervention of Stroke——Analysis of 700 Thousand People in Nanhui County of Shanghai City
下载PDF
导出
摘要 卒中“高危人群筛选与干预策略”是大众预防策略和高危预防策略的结合,在上海市70万人群试点预防中取得良好效果。筛选手段分年龄、危险因素暴露水平和临床实验室检查3个层面,干预措施包括健康教育、危险因素控制和药物重点预防3个层面。试点预防证实,脑血管血流动力学检测应用于高危人群筛检具有良好的效能,脑安胶囊作为重点干预药物具有良好的效果。提高医师的预防意识,在卒中社区预防和临床预防中按层次筛选高危人群,实施科学的预防方案,对于提高预防卒中效果具有重要意义。 High risk population screening and intervention strategy of stroke was a combination of popular and high risk prevention. It had achieved a considerable effect for 700 thousand people in Nanhui county of Shanghai city. Screening measures included three strata of age, exposure of risk factors and clinical examination. Intervention measures included health education, control of risk factors and stressed medical prevention. The trial prevention in Nanhui county indicated that cerebral vascular hemodynamic examination was a sensitive measure for screening high risk population. Nao'an Capsule was effective for preventing stroke. It is important that to enhance preventive consciousness of physicians, to select rational screening measures both in community prevention and clinical prevention, and to implement a scientific prevention project.
出处 《中国全科医学》 CAS CSCD 2006年第5期409-410,共2页 Chinese General Practice
基金 上海市专项基金(沪科合99第005号)
关键词 卒中 一级预防 筛检 干预 Stoke Primary prevention Screening Intervention
  • 相关文献

参考文献10

二级参考文献20

  • 1American Heart Association. Primary prevention of ischemic stroke. Circulation,2001,103 : 163-182.
  • 2D'Agostino RB, Wolf PA, Belanger AJ, et al. Stroke risk profile:adjustment for antihypertensive medication: the Framingham Study. Stroke, 1994,25:40-43.
  • 3O' Rourke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention. CMAJ, 2004,170 : 1123-1133.
  • 4Hart RG, Halperin JL, McBride R, et al. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol,2000,57 : 326-332.
  • 5Collaboration meta analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration.BMJ ,2002,324: 71-86.
  • 6Bosch J, Yusuf S, Pogue J, et al. HOPE investigators. Heart outcomes prevention evaluation. Use of ramiprll in preventing stroke: double blind randomized trial. BMJ, 2002,324:699-702.
  • 7Sever PS, Dahlof B, Pouher NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-- Lipid Lowering Arm(ASCOT-LLA) : a muhicentre randomized controlled trial. Lancet,2003,361 : 1149-1158.
  • 8Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S). Lancet, 1994,344:1383-1389.
  • 9郭佐 王桂清 何广成 等 柳兆荣 主编.脑血管血流动力学参数的主成分分析和脑血管功能的综合评估[A].柳兆荣,主编.生物力学新近展[C].成都:成都科技大学出版社,1996.260-264.
  • 10张学斌,陈静,李丽萍.脑循环血液动力学指标在脑血管病临床中的应用[J].转化医学杂志,2000(4):211-214. 被引量:15

共引文献203

同被引文献88

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部